Document Detail


The association between cadmium, lead and mercury blood levels and reproductive hormones among healthy, premenopausal women.
MedLine Citation:
PMID:  21778284     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Cadmium, lead and mercury have been identified in human follicular fluid and ovarian tissue, and have been associated with adverse reproductive outcomes in epidemiologic studies; however, few studies have examined the relationship between blood metal levels and reproductive hormones.
METHODS: Among 252 premenopausal women aged 18-44 years, we examined the association between blood metal levels (cadmium, lead and mercury), cycle length, and reproductive hormones [FSH, LH, estradiol (E(2)) and progesterone] measured at clinically relevant time points in the menstrual cycle. The association between metal levels (continuous) and hormone levels was assessed using linear regression with hormone levels (natural) log transformed and the results interpreted as the percentage difference in hormone level per unit increase in metal level.
RESULTS: Median (interquartile range) cadmium, lead and mercury levels were 0.30 µg/l (0.19, 0.43), 0.87 µg/dl (0.68, 1.20) and 1.10 µg/l (0.58, 2.10), respectively. Each 1 µg/l increase in cadmium levels was associated with a 21% [95% confidence interval (CI): -2.9, 49.9] increase in early follicular phase E(2) levels after adjusting for age, race/ethnicity, lead and mercury. This association decreased when restricted to never smokers (10%; 95% CI: -19.5, 51.3). Cadmium was also associated with a non-significant 9% (95% CI: -0.2, 19.9), or 2.7 day, increase in cycle length among never smokers. No associations were observed between lead or mercury and the outcomes in adjusted analyses.
CONCLUSIONS: Further evaluation of the association between cadmium, E(2) and cycle length is warranted, taking into consideration cigarette smoke and its multiple components.
Authors:
L W Jackson; P P Howards; J Wactawski-Wende; E F Schisterman
Related Documents :
21801354 - A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinic...
7520014 - Increase in serum alpha-fetoprotein without recurrent disease after hepatectomy for hep...
22095984 - Association of testosterone levels with endothelial function in men: results from a pop...
7142674 - Melanocyte-stimulating activity in fetal, newborn and adult guinea-pigs: studies of the...
21801354 - A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinic...
8964844 - Type ii and type iii deiodinase activity in human placenta as a function of gestational...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural     Date:  2011-07-21
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  26     ISSN:  1460-2350     ISO Abbreviation:  Hum. Reprod.     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-09-16     Completed Date:  2012-03-25     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  England    
Other Details:
Languages:  eng     Pagination:  2887-95     Citation Subset:  IM    
Affiliation:
Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4945, USA. leila.jackson@case.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Cadmium / blood*
Estradiol / blood
Female
Follicle Stimulating Hormone / blood
Gene Expression Regulation / drug effects
Humans
Lead / blood*
Luteinizing Hormone / blood
Menstrual Cycle
Mercury / blood*
Models, Statistical
Progesterone / blood
Regression Analysis
Treatment Outcome
Chemical
Reg. No./Substance:
50-28-2/Estradiol; 57-83-0/Progesterone; 7439-92-1/Lead; 7439-97-6/Mercury; 7440-43-9/Cadmium; 9002-67-9/Luteinizing Hormone; 9002-68-0/Follicle Stimulating Hormone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IV...
Next Document:  The legacy of sperm banking: how fertility monitoring and disposal of sperm are linked with views of...